外周渗出性出血性脉络膜视网膜病变诊断及治疗研究进展  

Research progress in the diagnosis and treatment of peripheral exudative hemorrhagic choroidal retinopathy

作　　者：贺紫彤 于金国[1] He Zitong;Yu Jinguo(Department of Ophthalmology,General Hospital of Tianjin Medical University,Tianjin 300072,China)

机构地区：[1]天津医科大学总医院眼科,天津300072

出　　处：《中华眼底病杂志》2023年第11期949-953,共5页Chinese Journal of Ocular Fundus Diseases

摘　　要：外周渗出性出血性脉络膜视网膜病变(PEHCR)是以视网膜下出血和(或)视网膜色素上皮下出血或渗出为主要特征的周边视网膜疾病,常被误诊为老年性黄斑变性、息肉样脉络膜血管病变或脉络膜黑色素瘤等。随着多模式影像学发展,PEHCR在B型超声、荧光素眼底血管造影、光相干断层扫描等检查中表现出不同特征,据此可与上述疾病鉴别。该病治疗方法包括激光光凝治疗、玻璃体腔注射抗血管内皮生长因子药物和玻璃体切割手术等,但目前尚无统一治疗标准。未来仍需进一步深入了解PEHCR临床特征、治疗方案及预后,最大程度避免临床漏诊与误诊,提高治疗效率。Peripheral exudative hemorrhagic chorioretinopathy(PEHCR)is a peripheral retinal disease characterized by subretinal hemorrhage and/or subretinal pigment epithelial hemorrhage or exudation.It is often misdiagnosed as age-related macular degeneration,polypoidal chorioretinopathy or choroidal melanoma.With the development of multimodal imaging,PEHCR has different features under different examinations,such as Bscan ultrasound,fluorescein fundus angiography,optical coherence tomography and so on,which contributes to differention from other diseases.Clinical treatments for the disease include intravitreal injection of retinal photocoagulation therapy,anti-vascular endothelial growth factor,pars plana vitrectomyand so on,but there is still no universal consensus.In order to gain a deeper understanding of the clinical features,treatment options and prognosis of PEHCR,minimize missed diagnoses and misdiagnoses,and improve treatment efficiency,further research is required.

关 键 词：外周渗出性出血性脉络膜视网膜病变 脉络膜黑色素瘤 多模式影像 综述 

分 类 号：R774.1[医药卫生—眼科]